A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.
Original languageEnglish
Pages (from-to)14-14
Number of pages1
JournalPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume18
Publication statusPublished - 2020

Cite this